Background: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder for which
no diagnostic tools are currently available. Patients are diagnosed using the Rome IV …

Background The diagnosis of irritable bowel syndrome (IBS) is challenging because of its
heterogeneity and multifactorial pathophysiology. No reliable biomarkers of IBS have been …

Background Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disease
characterized by intermittent abdominal pain with altered bowel habits. Due to the …

Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to
invasive investigations in order to rule out other diseases and reassure their patients …

Irritable bowel syndrome (IBS) is a chronic gastrointestinal (GI) disorder characterized by
altered bowel habits and abdominal discomfort during defecation. It significantly impacts life …

Volatile organic compounds (VOCs) are produced by the human metabolism, inflammation
and gut microbiota and form the basis of innovative volatomics research. VOCs detected …

Irritable bowel syndrome (IBS) is diagnosed by subjective clinical symptoms. We aimed to
establish an objective IBS prediction model based on gut microbiome analyses employing …

Background & Aims Dietary interventions are effective in management of patients with
irritable bowel syndrome (IBS), although responses vary. We investigated whether fecal …

Introduction Early inflammatory bowel disease (IBD) diagnosis remains a clinical challenge.
Volatile organic compounds (VOCs) have shown distinct patterns in Crohn's disease (CD) …

Introduction VOCs can be utilised as non invasive biomarkers for gastrointestinal diseases
such as IBD, as changes in VOCs reflect internal metabolical and pathological processes …